6-K ·Filed May 18, 2026

CCM

Concord Medical Services Holdings Ltd
NEUTRAL
Impact 4/10
Horizonweeks Processed4mo ago SEC0001104659-26-062981
Notable filing: 6-K
Actionable Insight • Neutral

Monitor for management's determination on Concord Healthcare's consolidation status, as deconsolidation could significantly alter CCM's reported revenue and asset base. The stock may see volatility on any announcement regarding this review.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
CCM ▼ -7.35% at T+60d
NEUTRAL call ✗ call lost -7.35% · α vs SPY -12.20% · entry $5.17 → $4.79
Entry anchored
May 18, 2026
via day open
T+1d
-4.45%
call -4.45% · α -3.80%
$4.94
settled 5mo ago
T+5d
-5.42%
call -5.42% · α -7.03%
$4.89
settled 4mo ago
T+20d
-9.09%
call -9.09% · α -10.67%
$4.70
settled 4mo ago
T+60d
-7.35%
call -7.35% · α -12.20%
$4.79
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Concord Medical Services Holdings Ltd filed a 6-K reporting that Mr. Liang Chang resigned as an executive director of its subsidiary, Concord Healthcare Group Co., Ltd., effective May 11, 2026, and Ms. Li Jiang was elected as an employee director on the same day. Management is reviewing whether Concord Healthcare still qualifies as a consolidated subsidiary under applicable accounting standards, creating uncertainty about the company's financial structure.

Key Facts

  • Mr. Liang Chang resigned as executive director of Concord Healthcare effective May 11, 2026.
  • Ms. Li Jiang was elected as an employee director of Concord Healthcare on May 11, 2026.
  • Management is reviewing whether Concord Healthcare remains a consolidated subsidiary of the company.
  • No financial figures or material financial impact were disclosed in the filing.

Financial Impact

No financial impact quantified; potential deconsolidation of Concord Healthcare could materially affect reported financials, but outcome is uncertain.

revenuenet incometotal assetsconsolidation status

Risk Factors

  • Deconsolidation of Concord Healthcare could materially reduce reported revenue and assets.
  • Uncertainty around the review timeline and outcome may weigh on investor sentiment.
  • The filing provides no financial details, limiting near-term trading catalysts.

Market Snapshot

Exchange
NYSE
Sector
Services-Offices & Clinics of Doctors of Medicine
Analyst Consensus
0% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-062981
Document: 0001104659-26-062981-index-headers.html0001104659-26-062981
Document: 0001104659-26-062981-index.html0001104659-26-062981
Document: 0001104659-26-062981.txt0001104659-26-062981
3 reports for CCM
Performance horizon
Filters
Rows
Reports for CCM — sortable, filterable
TypeNow
Jul 2, 2026
13w ago
6-K
NEUTRAL ★ 3/10
$4.39 $3.56▼ −18.91%▼ −21.91%$3.17 (−27.79%)
May 18, 2026
19w ago
6-K
NEUTRAL ★ 4/10
$5.17 $4.79▼ −7.35%▼ −12.20%$3.17 (−38.68%)
May 13, 2026
20w ago
6-K
NEUTRAL ★ 2/10
$5.35 $4.53▼ −15.33%▼ −19.76%$3.17 (−40.75%)
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (37h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access